Fortress Biotech Inc (NAS:FBIO)

$ 1.7 0.03 (1.8%) Market Cap: 32.70 Mil Enterprise Value: 35.86 Mil PE Ratio: 0 PB Ratio: 1.14 GF Score: 50/100

Fortress Biotech Inc Extraordinary Shareholders Meeting Transcript
Oct 09, 2023
Fortress Biotech Inc Annual Shareholders Meeting Transcript
Jun 21, 2023
Fortress Biotech Inc Extraordinary Shareholders Meeting Transcript
Apr 10, 2023
Fortress Biotech Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 15, 2023
Fortress Biotech Inc at ROTH Conference Transcript
Mar 13, 2023
Fortress Biotech Inc Annual Shareholders Meeting Transcript
Jun 21, 2022
Fortress Biotech Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Feb 09, 2022
Fortress Biotech Inc Corporate Update Presentation at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
Sep 30, 2021
Fortress Biotech Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) Transcript
Sep 20, 2021
Fortress Biotech Inc at SNN Network Virtual Conference Transcript
Aug 05, 2020
Fortress Biotech Inc at SNN Network Virtual Conference Transcript
Aug 03, 2020
Fortress Biotech Inc at Planet MicroCap Showcase Virtual Investor Conference 2020 Transcript
Apr 29, 2020

Fortress Biotech Inc Annual Shareholders Meeting Transcript

Jun 21, 2023 / 02:00PM GMT

Release Date Price: $9 (-6.25%)

Transcript

Operator

Good day and welcome to the Fortress Biotech, Inc. 2023 Annual Stockholders' Meeting. (Operator Instructions) I would now like to turn the conference over to Lindsay A. Rosenwald, please go ahead.

Lindsay A. Rosenwald

Fortress Biotech, Inc. - Chairman, President, & CEO

Thank you. Good morning. I'm Lindsay A. Rosenwald, Executive Chairman and President and CEO of Fortress Biotech, and I will be presiding over today's virtual meeting of stockholders. On behalf of our company, I want to welcome you to our 2023 Annual Meeting of Shareholders, which is now formally called to order. We are very pleased to have each of you in attendance at today's virtual meeting.

Let me begin by introducing the directors of the company in attendance via remote communication. With us today are Dr. Eric Rowinsky, Dr. Jimmie Harvey, Malcolm Hoenlein, Dov Klein, Jay Lobell, Kevin Lorenz, Dr. Lucy Lu, and Michael S. Weiss.

Also present here today is Mark Drozdowski of KPMG LLP, our independent auditors for the year ending December 31, 2022; and Rakesh Gopalan of

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.